newsfilter
← Latest News
GlobeNewswire·

Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics' Board of Directors

CAMBRIDGE, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced the appointment of Steven E.